-
-
-
-
-
-
-
Vera Therapeutics moves up atacicept analysis timeline with FDA agreement
-
-
-
-
-
-
-
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
-
-
-
-
-
-
-
Vera Therapeutics (VERA) Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN
-
-
-
-
15,464 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

